KLK3 and prostate carcinoma: A similar study conducted by Chiu et al. achieved to build an ANN model of predicting bone metastases in prostate carcinoma patients using PSA levels and patients' age like inputs variables with good sensitivity (87.5%) and specificity (83.3%) [28].